Acrylonitrile


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
1000 CDH2 Increases expression PMID:30236600
100506658 OCLN Decreases expression PMID:30236600
100506742 CASP12 Increases expression PMID:33132245
1026 CDKN1A Affects expression PMID:10451498; PMID:26332274; PMID:30236600; PMID:33132245
1027 CDKN1B Affects expression PMID:30236600; PMID:33132245
1491 CTH Decreases expression PMID:33486070
1571 CYP2E1 Increases expression PMID:26332274
1649 DDIT3 Increases expression PMID:33132245; PMID:35429547
1728 NQO1 Increases activity PMID:9029048
1728 NQO1 Increases expression PMID:9029048
1965 EIF2S1 Increases expression PMID:33132245
2353 FOS Decreases expression PMID:16173056
2475 MTOR Increases expression PMID:35429547
2547 XRCC6 Increases expression PMID:26332274
27301 APEX2 Increases expression PMID:26332274
2878 GPX3 Increases expression PMID:35429547
3014 H2AX Increases expression PMID:35429547
3091 HIF1A Decreases expression PMID:39615733
3162 HMOX1 Increases expression PMID:14644359
3309 HSPA5 Increases expression PMID:35429547
3553 IL1B Increases expression PMID:26332274
3569 IL6 Increases expression PMID:35429547
3725 JUN Decreases expression PMID:16173056
4357 MPST Decreases expression PMID:33486070
5335 PLCG1 Increases expression PMID:12850505
5599 MAPK8 Increases expression PMID:35429547
581 BAX Increases expression PMID:16173056; PMID:20981856; PMID:33132245; PMID:35429547; PMID:39615733
595 CCND1 Affects expression PMID:26332274; PMID:30236600; PMID:33132245
596 BCL2 Decreases expression PMID:16173056; PMID:35429547; PMID:39615733
5970 RELA Increases expression PMID:35429547
598 BCL2L1 Decreases expression PMID:33132245
6279 S100A8 Decreases expression PMID:16173056
6347 CCL2 Affects expression PMID:16173056; PMID:26332274
6591 SNAI2 Increases expression PMID:30236600
664 BNIP3 Affects expression PMID:39615733
6647 SOD1 Increases expression PMID:35429547
6648 SOD2 Increases expression PMID:35429547
7124 TNF Increases expression PMID:26332274; PMID:35429547
7157 TP53 Increases expression PMID:33132245
7852 CXCR4 Decreases expression PMID:16173056
81631 MAP1LC3B Affects expression PMID:39615733
836 CASP3 Increases activity PMID:20981856
836 CASP3 Increases expression PMID:35429547
84557 MAP1LC3A Increases expression PMID:35429547
847 CAT Decreases activity PMID:19913070; PMID:20127315
847 CAT Increases expression PMID:35429547
8678 BECN1 Affects expression PMID:35429547; PMID:39615733
875 CBS Decreases expression PMID:33486070
894 CCND2 Increases expression PMID:26332274
898 CCNE1 Affects expression PMID:30236600; PMID:33132245
9804 TOMM20 Increases expression PMID:39615733
999 CDH1 Decreases expression PMID:30236600

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.